nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Fluorouracil—skin cancer	0.359	0.567	CbGbCtD
Cefotaxime—SLC22A7—Docetaxel—skin cancer	0.274	0.433	CbGbCtD
Cefotaxime—Superinfection—Fluorouracil—skin cancer	0.0125	0.0342	CcSEcCtD
Cefotaxime—Induration—Imiquimod—skin cancer	0.0115	0.0314	CcSEcCtD
Cefotaxime—Local reaction—Imiquimod—skin cancer	0.00931	0.0254	CcSEcCtD
Cefotaxime—Traumatic liver injury—Temozolomide—skin cancer	0.00829	0.0226	CcSEcCtD
Cefotaxime—Induration—Bleomycin—skin cancer	0.00819	0.0223	CcSEcCtD
Cefotaxime—Enterocolitis—Docetaxel—skin cancer	0.0074	0.0202	CcSEcCtD
Cefotaxime—Local reaction—Bleomycin—skin cancer	0.00662	0.018	CcSEcCtD
Cefotaxime—Nephropathy toxic—Bleomycin—skin cancer	0.00638	0.0174	CcSEcCtD
Cefotaxime—Tenderness—Imiquimod—skin cancer	0.00591	0.0161	CcSEcCtD
Cefotaxime—Bullous eruption—Docetaxel—skin cancer	0.0052	0.0142	CcSEcCtD
Cefotaxime—Vaginal inflammation—Imiquimod—skin cancer	0.00516	0.0141	CcSEcCtD
Cefotaxime—Local reaction—Fluorouracil—skin cancer	0.00514	0.014	CcSEcCtD
Cefotaxime—Vaginal infection—Imiquimod—skin cancer	0.00487	0.0133	CcSEcCtD
Cefotaxime—Encephalopathy—Fluorouracil—skin cancer	0.00444	0.0121	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Imiquimod—skin cancer	0.00428	0.0117	CcSEcCtD
Cefotaxime—Tenderness—Bleomycin—skin cancer	0.0042	0.0114	CcSEcCtD
Cefotaxime—Cholestasis—Temozolomide—skin cancer	0.00407	0.0111	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00395	0.0108	CcSEcCtD
Cefotaxime—Eosinophilia—Vemurafenib—skin cancer	0.00376	0.0102	CcSEcCtD
Cefotaxime—Liver injury—Temozolomide—skin cancer	0.00367	0.01	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00335	0.00914	CcSEcCtD
Cefotaxime—Tenderness—Fluorouracil—skin cancer	0.00326	0.00889	CcSEcCtD
Cefotaxime—Aplastic anaemia—Dactinomycin—skin cancer	0.00321	0.00874	CcSEcCtD
Cefotaxime—Vaginal inflammation—Temozolomide—skin cancer	0.00309	0.00842	CcSEcCtD
Cefotaxime—Pain—Vismodegib—skin cancer	0.00299	0.00814	CcSEcCtD
Cefotaxime—Candida infection—Temozolomide—skin cancer	0.00295	0.00804	CcSEcCtD
Cefotaxime—Vaginal infection—Temozolomide—skin cancer	0.00292	0.00795	CcSEcCtD
Cefotaxime—Aplastic anaemia—Temozolomide—skin cancer	0.0029	0.00791	CcSEcCtD
Cefotaxime—Erythema multiforme—Vemurafenib—skin cancer	0.00287	0.00782	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00286	0.00779	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vismodegib—skin cancer	0.00286	0.00778	CcSEcCtD
Cefotaxime—Abdominal pain—Vismodegib—skin cancer	0.00276	0.00752	CcSEcCtD
Cefotaxime—Haemoglobin—Imiquimod—skin cancer	0.0026	0.00709	CcSEcCtD
Cefotaxime—Haemorrhage—Imiquimod—skin cancer	0.00259	0.00706	CcSEcCtD
Cefotaxime—Pruritus—Vismodegib—skin cancer	0.00247	0.00673	CcSEcCtD
Cefotaxime—Erythema multiforme—Imiquimod—skin cancer	0.00245	0.00667	CcSEcCtD
Cefotaxime—Diarrhoea—Vismodegib—skin cancer	0.00239	0.00651	CcSEcCtD
Cefotaxime—Arrhythmia—Imiquimod—skin cancer	0.00231	0.0063	CcSEcCtD
Cefotaxime—Bronchospasm—Bleomycin—skin cancer	0.00226	0.00616	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00223	0.00609	CcSEcCtD
Cefotaxime—Vomiting—Vismodegib—skin cancer	0.00222	0.00605	CcSEcCtD
Cefotaxime—Rash—Vismodegib—skin cancer	0.0022	0.006	CcSEcCtD
Cefotaxime—Dermatitis—Vismodegib—skin cancer	0.0022	0.00599	CcSEcCtD
Cefotaxime—Dermatitis bullous—Fluorouracil—skin cancer	0.00216	0.00589	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vemurafenib—skin cancer	0.00216	0.00588	CcSEcCtD
Cefotaxime—Ill-defined disorder—Imiquimod—skin cancer	0.00209	0.0057	CcSEcCtD
Cefotaxime—Nausea—Vismodegib—skin cancer	0.00207	0.00565	CcSEcCtD
Cefotaxime—Angioedema—Imiquimod—skin cancer	0.00206	0.00561	CcSEcCtD
Cefotaxime—Malaise—Imiquimod—skin cancer	0.00203	0.00554	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00202	0.0055	CcSEcCtD
Cefotaxime—Neutropenia—Dactinomycin—skin cancer	0.002	0.00546	CcSEcCtD
Cefotaxime—Colitis—Docetaxel—skin cancer	0.00197	0.00538	CcSEcCtD
Cefotaxime—Candida infection—Docetaxel—skin cancer	0.00196	0.00535	CcSEcCtD
Cefotaxime—Convulsion—Imiquimod—skin cancer	0.00195	0.00532	CcSEcCtD
Cefotaxime—Discomfort—Imiquimod—skin cancer	0.0019	0.00517	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00189	0.00516	CcSEcCtD
Cefotaxime—Haemoglobin—Bleomycin—skin cancer	0.00185	0.00504	CcSEcCtD
Cefotaxime—Haemorrhage—Bleomycin—skin cancer	0.00184	0.00501	CcSEcCtD
Cefotaxime—Neutropenia—Temozolomide—skin cancer	0.00181	0.00494	CcSEcCtD
Cefotaxime—Shock—Imiquimod—skin cancer	0.00181	0.00493	CcSEcCtD
Cefotaxime—Agranulocytosis—Dactinomycin—skin cancer	0.00178	0.00486	CcSEcCtD
Cefotaxime—Eosinophilia—Fluorouracil—skin cancer	0.00177	0.00482	CcSEcCtD
Cefotaxime—Hepatitis—Dactinomycin—skin cancer	0.00172	0.00468	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00171	0.00467	CcSEcCtD
Cefotaxime—Body temperature increased—Vemurafenib—skin cancer	0.00171	0.00465	CcSEcCtD
Cefotaxime—Erythema multiforme—Dactinomycin—skin cancer	0.00162	0.00442	CcSEcCtD
Cefotaxime—Hypersensitivity—Vemurafenib—skin cancer	0.00159	0.00433	CcSEcCtD
Cefotaxime—Pain—Imiquimod—skin cancer	0.00157	0.00429	CcSEcCtD
Cefotaxime—Renal impairment—Docetaxel—skin cancer	0.00157	0.00427	CcSEcCtD
Cefotaxime—Dermatitis bullous—Docetaxel—skin cancer	0.00156	0.00425	CcSEcCtD
Cefotaxime—Haemoglobin—Temozolomide—skin cancer	0.00156	0.00425	CcSEcCtD
Cefotaxime—Hepatitis—Temozolomide—skin cancer	0.00155	0.00423	CcSEcCtD
Cefotaxime—Haemorrhage—Temozolomide—skin cancer	0.00155	0.00423	CcSEcCtD
Cefotaxime—Pruritus—Vemurafenib—skin cancer	0.00153	0.00416	CcSEcCtD
Cefotaxime—Feeling abnormal—Imiquimod—skin cancer	0.00152	0.00413	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Imiquimod—skin cancer	0.0015	0.0041	CcSEcCtD
Cefotaxime—Agranulocytosis—Fluorouracil—skin cancer	0.00149	0.00405	CcSEcCtD
Cefotaxime—Ill-defined disorder—Bleomycin—skin cancer	0.00149	0.00405	CcSEcCtD
Cefotaxime—Diarrhoea—Vemurafenib—skin cancer	0.00148	0.00402	CcSEcCtD
Cefotaxime—Erythema multiforme—Temozolomide—skin cancer	0.00147	0.004	CcSEcCtD
Cefotaxime—Urticaria—Imiquimod—skin cancer	0.00146	0.00398	CcSEcCtD
Cefotaxime—Body temperature increased—Imiquimod—skin cancer	0.00145	0.00396	CcSEcCtD
Cefotaxime—Abdominal pain—Imiquimod—skin cancer	0.00145	0.00396	CcSEcCtD
Cefotaxime—Malaise—Bleomycin—skin cancer	0.00144	0.00394	CcSEcCtD
Cefotaxime—Haemoglobin—Fluorouracil—skin cancer	0.00144	0.00392	CcSEcCtD
Cefotaxime—Leukopenia—Bleomycin—skin cancer	0.00143	0.00391	CcSEcCtD
Cefotaxime—Haemorrhage—Fluorouracil—skin cancer	0.00143	0.0039	CcSEcCtD
Cefotaxime—Ill-defined disorder—Dactinomycin—skin cancer	0.00139	0.00378	CcSEcCtD
Cefotaxime—Vomiting—Vemurafenib—skin cancer	0.00137	0.00374	CcSEcCtD
Cefotaxime—Rash—Vemurafenib—skin cancer	0.00136	0.00371	CcSEcCtD
Cefotaxime—Dermatitis—Vemurafenib—skin cancer	0.00136	0.0037	CcSEcCtD
Cefotaxime—Hypersensitivity—Imiquimod—skin cancer	0.00136	0.00369	CcSEcCtD
Cefotaxime—Headache—Vemurafenib—skin cancer	0.00135	0.00368	CcSEcCtD
Cefotaxime—Discomfort—Bleomycin—skin cancer	0.00135	0.00367	CcSEcCtD
Cefotaxime—Malaise—Dactinomycin—skin cancer	0.00135	0.00367	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00134	0.00366	CcSEcCtD
Cefotaxime—Leukopenia—Dactinomycin—skin cancer	0.00134	0.00364	CcSEcCtD
Cefotaxime—Anaphylactic shock—Bleomycin—skin cancer	0.00131	0.00356	CcSEcCtD
Cefotaxime—Pruritus—Imiquimod—skin cancer	0.0013	0.00355	CcSEcCtD
Cefotaxime—Nausea—Vemurafenib—skin cancer	0.00128	0.00349	CcSEcCtD
Cefotaxime—Thrombocytopenia—Bleomycin—skin cancer	0.00128	0.00349	CcSEcCtD
Cefotaxime—Arrhythmia—Fluorouracil—skin cancer	0.00128	0.00348	CcSEcCtD
Cefotaxime—Bronchospasm—Docetaxel—skin cancer	0.00127	0.00346	CcSEcCtD
Cefotaxime—Diarrhoea—Imiquimod—skin cancer	0.00126	0.00343	CcSEcCtD
Cefotaxime—Discomfort—Dactinomycin—skin cancer	0.00126	0.00342	CcSEcCtD
Cefotaxime—Ill-defined disorder—Temozolomide—skin cancer	0.00125	0.00342	CcSEcCtD
Cefotaxime—Angioedema—Temozolomide—skin cancer	0.00123	0.00336	CcSEcCtD
Cefotaxime—Malaise—Temozolomide—skin cancer	0.00122	0.00332	CcSEcCtD
Cefotaxime—Leukopenia—Temozolomide—skin cancer	0.00121	0.00329	CcSEcCtD
Cefotaxime—Neutropenia—Docetaxel—skin cancer	0.00121	0.00329	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dactinomycin—skin cancer	0.00119	0.00325	CcSEcCtD
Cefotaxime—Convulsion—Temozolomide—skin cancer	0.00117	0.00319	CcSEcCtD
Cefotaxime—Vomiting—Imiquimod—skin cancer	0.00117	0.00319	CcSEcCtD
Cefotaxime—Rash—Imiquimod—skin cancer	0.00116	0.00316	CcSEcCtD
Cefotaxime—Dermatitis—Imiquimod—skin cancer	0.00116	0.00316	CcSEcCtD
Cefotaxime—Headache—Imiquimod—skin cancer	0.00115	0.00314	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00114	0.00311	CcSEcCtD
Cefotaxime—Discomfort—Temozolomide—skin cancer	0.00114	0.0031	CcSEcCtD
Cefotaxime—Renal failure—Docetaxel—skin cancer	0.00113	0.00308	CcSEcCtD
Cefotaxime—Jaundice—Docetaxel—skin cancer	0.00112	0.00305	CcSEcCtD
Cefotaxime—Pain—Bleomycin—skin cancer	0.00112	0.00305	CcSEcCtD
Cefotaxime—Leukopenia—Fluorouracil—skin cancer	0.00111	0.00304	CcSEcCtD
Cefotaxime—Anaphylactic shock—Temozolomide—skin cancer	0.0011	0.003	CcSEcCtD
Cefotaxime—Nausea—Imiquimod—skin cancer	0.00109	0.00298	CcSEcCtD
Cefotaxime—Thrombocytopenia—Temozolomide—skin cancer	0.00108	0.00294	CcSEcCtD
Cefotaxime—Convulsion—Fluorouracil—skin cancer	0.00108	0.00294	CcSEcCtD
Cefotaxime—Feeling abnormal—Bleomycin—skin cancer	0.00108	0.00293	CcSEcCtD
Cefotaxime—Agranulocytosis—Docetaxel—skin cancer	0.00107	0.00292	CcSEcCtD
Cefotaxime—Discomfort—Fluorouracil—skin cancer	0.00105	0.00285	CcSEcCtD
Cefotaxime—Pain—Dactinomycin—skin cancer	0.00104	0.00284	CcSEcCtD
Cefotaxime—Urticaria—Bleomycin—skin cancer	0.00104	0.00283	CcSEcCtD
Cefotaxime—Haemoglobin—Docetaxel—skin cancer	0.00104	0.00283	CcSEcCtD
Cefotaxime—Body temperature increased—Bleomycin—skin cancer	0.00103	0.00282	CcSEcCtD
Cefotaxime—Haemorrhage—Docetaxel—skin cancer	0.00103	0.00281	CcSEcCtD
Cefotaxime—Hepatitis—Docetaxel—skin cancer	0.00103	0.00281	CcSEcCtD
Cefotaxime—Anaphylactic shock—Fluorouracil—skin cancer	0.00102	0.00277	CcSEcCtD
Cefotaxime—Feeling abnormal—Dactinomycin—skin cancer	0.001	0.00274	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dactinomycin—skin cancer	0.000997	0.00272	CcSEcCtD
Cefotaxime—Thrombocytopenia—Fluorouracil—skin cancer	0.000995	0.00271	CcSEcCtD
Cefotaxime—Erythema multiforme—Docetaxel—skin cancer	0.000976	0.00266	CcSEcCtD
Cefotaxime—Abdominal pain—Dactinomycin—skin cancer	0.000964	0.00263	CcSEcCtD
Cefotaxime—Body temperature increased—Dactinomycin—skin cancer	0.000964	0.00263	CcSEcCtD
Cefotaxime—Hypersensitivity—Bleomycin—skin cancer	0.000963	0.00262	CcSEcCtD
Cefotaxime—Pain—Temozolomide—skin cancer	0.000943	0.00257	CcSEcCtD
Cefotaxime—Pruritus—Bleomycin—skin cancer	0.000925	0.00252	CcSEcCtD
Cefotaxime—Arrhythmia—Docetaxel—skin cancer	0.000922	0.00251	CcSEcCtD
Cefotaxime—Feeling abnormal—Temozolomide—skin cancer	0.000908	0.00248	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Temozolomide—skin cancer	0.000901	0.00246	CcSEcCtD
Cefotaxime—Hypersensitivity—Dactinomycin—skin cancer	0.000898	0.00245	CcSEcCtD
Cefotaxime—Urticaria—Temozolomide—skin cancer	0.000876	0.00239	CcSEcCtD
Cefotaxime—Abdominal pain—Temozolomide—skin cancer	0.000871	0.00237	CcSEcCtD
Cefotaxime—Body temperature increased—Temozolomide—skin cancer	0.000871	0.00237	CcSEcCtD
Cefotaxime—Pain—Fluorouracil—skin cancer	0.000869	0.00237	CcSEcCtD
Cefotaxime—Feeling abnormal—Fluorouracil—skin cancer	0.000837	0.00228	CcSEcCtD
Cefotaxime—Diarrhoea—Dactinomycin—skin cancer	0.000834	0.00227	CcSEcCtD
Cefotaxime—Vomiting—Bleomycin—skin cancer	0.000831	0.00226	CcSEcCtD
Cefotaxime—Rash—Bleomycin—skin cancer	0.000824	0.00225	CcSEcCtD
Cefotaxime—Dermatitis—Bleomycin—skin cancer	0.000823	0.00224	CcSEcCtD
Cefotaxime—Hypersensitivity—Temozolomide—skin cancer	0.000812	0.00221	CcSEcCtD
Cefotaxime—Urticaria—Fluorouracil—skin cancer	0.000807	0.0022	CcSEcCtD
Cefotaxime—Leukopenia—Docetaxel—skin cancer	0.000804	0.00219	CcSEcCtD
Cefotaxime—Body temperature increased—Fluorouracil—skin cancer	0.000803	0.00219	CcSEcCtD
Cefotaxime—Pruritus—Temozolomide—skin cancer	0.00078	0.00213	CcSEcCtD
Cefotaxime—Convulsion—Docetaxel—skin cancer	0.000778	0.00212	CcSEcCtD
Cefotaxime—Nausea—Bleomycin—skin cancer	0.000776	0.00212	CcSEcCtD
Cefotaxime—Vomiting—Dactinomycin—skin cancer	0.000775	0.00211	CcSEcCtD
Cefotaxime—Rash—Dactinomycin—skin cancer	0.000769	0.00209	CcSEcCtD
Cefotaxime—Diarrhoea—Temozolomide—skin cancer	0.000754	0.00206	CcSEcCtD
Cefotaxime—Hypersensitivity—Fluorouracil—skin cancer	0.000748	0.00204	CcSEcCtD
Cefotaxime—Anaphylactic shock—Docetaxel—skin cancer	0.000733	0.002	CcSEcCtD
Cefotaxime—Nausea—Dactinomycin—skin cancer	0.000724	0.00197	CcSEcCtD
Cefotaxime—Shock—Docetaxel—skin cancer	0.000721	0.00197	CcSEcCtD
Cefotaxime—Pruritus—Fluorouracil—skin cancer	0.000719	0.00196	CcSEcCtD
Cefotaxime—Thrombocytopenia—Docetaxel—skin cancer	0.000718	0.00196	CcSEcCtD
Cefotaxime—Vomiting—Temozolomide—skin cancer	0.000701	0.00191	CcSEcCtD
Cefotaxime—Rash—Temozolomide—skin cancer	0.000695	0.00189	CcSEcCtD
Cefotaxime—Diarrhoea—Fluorouracil—skin cancer	0.000695	0.00189	CcSEcCtD
Cefotaxime—Dermatitis—Temozolomide—skin cancer	0.000694	0.00189	CcSEcCtD
Cefotaxime—Headache—Temozolomide—skin cancer	0.000691	0.00188	CcSEcCtD
Cefotaxime—Nausea—Temozolomide—skin cancer	0.000655	0.00178	CcSEcCtD
Cefotaxime—Vomiting—Fluorouracil—skin cancer	0.000646	0.00176	CcSEcCtD
Cefotaxime—Rash—Fluorouracil—skin cancer	0.00064	0.00175	CcSEcCtD
Cefotaxime—Dermatitis—Fluorouracil—skin cancer	0.00064	0.00174	CcSEcCtD
Cefotaxime—Headache—Fluorouracil—skin cancer	0.000636	0.00173	CcSEcCtD
Cefotaxime—Pain—Docetaxel—skin cancer	0.000627	0.00171	CcSEcCtD
Cefotaxime—Feeling abnormal—Docetaxel—skin cancer	0.000604	0.00165	CcSEcCtD
Cefotaxime—Nausea—Fluorouracil—skin cancer	0.000603	0.00164	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Docetaxel—skin cancer	0.0006	0.00163	CcSEcCtD
Cefotaxime—Abdominal pain—Docetaxel—skin cancer	0.00058	0.00158	CcSEcCtD
Cefotaxime—Body temperature increased—Docetaxel—skin cancer	0.00058	0.00158	CcSEcCtD
Cefotaxime—Hypersensitivity—Docetaxel—skin cancer	0.00054	0.00147	CcSEcCtD
Cefotaxime—Pruritus—Docetaxel—skin cancer	0.000519	0.00141	CcSEcCtD
Cefotaxime—Diarrhoea—Docetaxel—skin cancer	0.000502	0.00137	CcSEcCtD
Cefotaxime—Vomiting—Docetaxel—skin cancer	0.000466	0.00127	CcSEcCtD
Cefotaxime—Rash—Docetaxel—skin cancer	0.000462	0.00126	CcSEcCtD
Cefotaxime—Dermatitis—Docetaxel—skin cancer	0.000462	0.00126	CcSEcCtD
Cefotaxime—Headache—Docetaxel—skin cancer	0.000459	0.00125	CcSEcCtD
Cefotaxime—Nausea—Docetaxel—skin cancer	0.000435	0.00119	CcSEcCtD
